Yahoo · Sep 4, 2026
Sumitomo Pharma (TSE:4506) Stock Looks Below Fair Value On Earnings Power
Sumitomo Pharma stock has delivered a very large 3 year gain but the broader valuation checks still suggest the shares trade on the cheap side compared with the fundamentals. After a weak year to date performance, the recent rebound raises the question of whether the stock still prices in too much caution or if expectations are finally catching up. Over the past 3 years, Sumitomo Pharma is up about 228.5% which signals a major re rating by the market over that window. The key support for the...
